BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32211407)

  • 1. Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa.
    Gao ML; Lei XL; Han F; He KW; Jin SQ; Zhang YY; Jin ZB
    Front Cell Dev Biol; 2020; 8():128. PubMed ID: 32211407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Correction Reverses Ciliopathy and Photoreceptor Loss in iPSC-Derived Retinal Organoids from Retinitis Pigmentosa Patients.
    Deng WL; Gao ML; Lei XL; Lv JN; Zhao H; He KW; Xia XX; Li LY; Chen YC; Li YP; Pan D; Xue T; Jin ZB
    Stem Cell Reports; 2018 Apr; 10(4):1267-1281. PubMed ID: 29526738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Human Patient iPSC-derived Retinal Organoids to Model Retinitis Pigmentosa.
    Ma C; Jin K; Jin ZB
    J Vis Exp; 2022 Jun; (184):. PubMed ID: 35786611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.
    Guo Y; Wang P; Ma JH; Cui Z; Yu Q; Liu S; Xue Y; Zhu D; Cao J; Li Z; Tang S; Chen J
    Front Cell Neurosci; 2019; 13():361. PubMed ID: 31481876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human retinal organoids harboring IMPG2 mutations exhibit a photoreceptor outer segment phenotype that models advanced retinitis pigmentosa.
    Mayerl SJ; Bajgai S; Ludwig AL; Jager LD; Williams BN; Bacig C; Stoddard C; Sinha D; Philpot BD; Gamm DM
    Stem Cell Reports; 2022 Nov; 17(11):2409-2420. PubMed ID: 36206764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosa.
    Sharma TP; Wiley LA; Whitmore SS; Anfinson KR; Cranston CM; Oppedal DJ; Daggett HT; Mullins RF; Tucker BA; Stone EM
    Stem Cell Res; 2017 May; 21():58-70. PubMed ID: 28390992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal organoids and microfluidic chip-based approaches to explore the retinitis pigmentosa with USH2A mutations.
    Su T; Liang L; Zhang L; Wang J; Chen L; Su C; Cao J; Yu Q; Deng S; Chan HF; Tang S; Guo Y; Chen J
    Front Bioeng Biotechnol; 2022; 10():939774. PubMed ID: 36185441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.
    Wiley LA; Burnight ER; DeLuca AP; Anfinson KR; Cranston CM; Kaalberg EE; Penticoff JA; Affatigato LM; Mullins RF; Stone EM; Tucker BA
    Sci Rep; 2016 Jul; 6():30742. PubMed ID: 27471043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue.
    Rodrigues A; Slembrouck-Brec A; Nanteau C; Terray A; Tymoshenko Y; Zagar Y; Reichman S; Xi Z; Sahel JA; Fouquet S; Orieux G; Nandrot EF; Byrne LC; Audo I; Roger JE; Goureau O
    NPJ Regen Med; 2022 Aug; 7(1):39. PubMed ID: 35974011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms.
    Forbes TA; Howden SE; Lawlor K; Phipson B; Maksimovic J; Hale L; Wilson S; Quinlan C; Ho G; Holman K; Bennetts B; Crawford J; Trnka P; Oshlack A; Patel C; Mallett A; Simons C; Little MH
    Am J Hum Genet; 2018 May; 102(5):816-831. PubMed ID: 29706353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal neovascularization induced by mutant
    Yan WM; Long P; Chen MZ; Wei DY; Wang JC; Zhang ZM; Zhang L; Chen T
    Int J Ophthalmol; 2021; 14(7):990-997. PubMed ID: 34282382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques to Quantify cGMP Dysregulation as a Common Pathway Associated with Photoreceptor Cell Death in Retinitis Pigmentosa.
    Yang P; Lockard RA; Titus H
    Adv Exp Med Biol; 2019; 1185():407-411. PubMed ID: 31884646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of PDE6B gene mutation and phenotype in Chinese cases with retinitis pigmentosa].
    Cui Y; Zhao KX; Wang L; Wang Q; Zhang W; Chen WY; Wang LM
    Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):28-32. PubMed ID: 12760810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-Onset X-Linked Retinitis Pigmentosa in a Heterozygous Female Harboring an Intronic Donor Splice Site Mutation in the Retinitis Pigmentosa GTPase Regulator Gene.
    Shifera AS; Kay CN
    Ophthalmic Genet; 2015; 36(3):251-6. PubMed ID: 24428633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
    Mitton KP; Guzman AE; Deshpande M; Byrd D; DeLooff C; Mkoyan K; Zlojutro P; Wallace A; Metcalf B; Laux K; Sotzen J; Tran T
    Mol Vis; 2014; 20():1527-44. PubMed ID: 25489226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: Concise Review.
    Artero Castro A; Rodríguez Jimenez FJ; Jendelova P; Erceg S
    Stem Cells; 2019 Dec; 37(12):1496-1504. PubMed ID: 31617949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in PDE6B causing human retinitis pigmentosa.
    Cheng LL; Han RY; Yang FY; Yu XP; Xu JL; Min QJ; Tian J; Ge XL; Zheng SS; Lin YW; Zheng YH; Qu J; Gu F
    Int J Ophthalmol; 2016; 9(8):1094-9. PubMed ID: 27588261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toward establishment of regenerative cell therapy for retinitis pigmentosa using iPS cell derived retinal sheet].
    Akiba R; Matsuyama T; Takahashi M; Mandai M
    Nihon Yakurigaku Zasshi; 2020; 155(2):93-98. PubMed ID: 32115485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genetic Basis of Pericentral Retinitis Pigmentosa-A Form of Mild Retinitis Pigmentosa.
    Comander J; Weigel-DiFranco C; Maher M; Place E; Wan A; Harper S; Sandberg MA; Navarro-Gomez D; Pierce EA
    Genes (Basel); 2017 Oct; 8(10):. PubMed ID: 28981474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.